In May 2026, Dexcom disclosed FDA-enforced, Class II voluntary recalls of its G7 and ONE/ONE+ iOS and watchOS apps worldwide due to a software defect that can delay or replay glucose readings and ...
For those in the diabetes community who’ve dreamed about seeing their in-the-moment blood sugar readings and trend data right on their smartwatch or bike computer while exercising, Dexcom and Garmin ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) and Companion Medical, Inc. today announced a collaboration to enable a direct exchange of CGM data from Dexcom with insulin data from InPen™ ...
Dexcom (DXCM) is leveraging AI to drive operational efficiency and product innovation, positioning itself as a platform ...
ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 ...
SAN FRANCISCO— Digital chronic care management company Livongo is partnering with Dexcom to integrate Dexcom's continuous glucose monitoring (CGM) device into its diabetes coaching platform. Dexcom is ...
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical ...
Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its ...
Dexcom and DreaMed Diabetes Announce Collaboration to Integrate Dexcom CGM Data into DreaMed Advisor
TEL AVIV, Israel--(BUSINESS WIRE)--DreaMed Diabetes Ltd., the developer of personalized diabetes management solutions, and DexCom Inc., the leader in continuous glucose monitoring (CGM) for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results